Rexio-AP

Rexio-AP

Each Film coated tablet contains : Aceclofenac 100 mg + Paracetamol 325 mg + Serratiopeptidase 15 mg ((as enteric coated)
Rexio-AP is a triple-action formulation designed to address inflammation, pain, and swelling. It is especially effective in musculoskeletal conditions due to its synergistic combination of anti-inflammatory, analgesic, and proteolytic enzyme components.

Mechanism of Action:

  • Aceclofenac inhibits the cyclooxygenase (COX) enzyme, thereby blocking the synthesis of prostaglandins, mediators of inflammation and pain.
  • Serratiopeptidase, a proteolytic enzyme, breaks down inflammatory exudates and fibrin deposits, facilitating tissue repair and faster healing.
  • Paracetamol acts centrally on the pain pathway, reducing pain perception without causing significant gastric irritation.

Indications:

  • Osteoarthritis
  • Rheumatoid arthritis
  • Ankylosing spondylitis
  • Back pain and neck pain
  • Sciatica
  • Sports injuries
  • Post-surgical pain and inflammation
  • Post-traumatic/accidental pain and inflammation
  • Post-procedural inflammation

Precautions:

  • May cause gastric discomfort, nausea, or vomiting
  • Should be used cautiously in patients with hepatic or renal insufficiency

Warnings:

  • Gastrointestinal risk: Prolonged use may increase the risk of ulcers, bleeding, or perforation
  • Hepatic risk: Use with caution in individuals with pre-existing liver conditions
  • Renal risk: Monitor kidney function in long-term use

Pharmacokinetics:

  • Route of Administration: Oral
  • Distribution: Widely distributed, including synovial fluid (Aceclofenac)
  • Metabolism: Primarily hepatic
  • Excretion: Mainly through urine

Contraindications:

  • Hypersensitivity to any component
  • Pregnancy and lactation
  • Active gastric ulcer or gastrointestinal bleeding

Side Effects:

  • Gastric hyperacidity
  • Acid dyspepsia
  • Flatulence
  • Nausea and vomiting

Dosage and Administration:

  • 1 tablet twice daily after food
  • Or as directed by the physician or healthcare provider
Ingredient Strength
Aceclofenac IP 100 mg
Paracetamol IP 325 mg
Serratiopeptidase (as enteric coated) IP 15 mg